Please assess the completion status of the following clinical trial:

Trial Title: Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and Women~* Ages 18-65~* Meet Rome III criteria for functional dyspepsia~* Endoscopy within 1 year~Exclusion Criteria:~* Allergic reaction or history of adverse events with Nortriptyline or tricyclic antidepressants~* Organic cause found on physical examination~* Organic cause found on lab work: Complete Blood Count, Comprehensive Metabolic Panel, Thyroid stimulating hormone, Tissue transglutaminase Immunoglobulin A~* Predominantly Gastroesophageal reflux symptoms~* Current Helicobacter pylori infection~* History of Peptic ulcer disease~* Non steroidal antiinflammatory use use \> 2x/wk~* Pregnant or planning pregnancy~* History of major depression~* Abdominal surgery in the last year

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Nortriptyline (Type: ACTIVE_COMPARATOR): Patients in this group will receive Nortriptyline 25mg at night for 8 weeks.
- Sugar pill (Type: PLACEBO_COMPARATOR): Patients in this group will receive an identical placebo capsule at night for 8 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).